Cavan John T 4
4 · Hepion Pharmaceuticals, Inc. · Filed Jul 25, 2019
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2019-07-24+5,820→ 6,059 totalExercise: $3.24Exp: 2029-07-24→ Common Stock (5,820 underlying)
Footnotes (1)
- [F1]Options vest in three installments as follows: 1,940 options shall vest on each of July 24, 2020, 2021 and 2022.